[Federal Register: September 21, 2007 (Volume 72, Number 183)]
[Notices]
[Page 54074-54075]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21se07-130]
-----------------------------------------------------------------------
DEPARTMENT OF LABOR
Employment and Training Administration
[TA-W-61,696]
Medtronic, Inc., Cardiovascular Division, Santa Rosa, CA; Notice
of Negative Determination on Reconsideration
On August 16, 2007, the Department issued an Affirmative
Determination Regarding Application for Reconsideration for the workers
and former workers of Medtronic, Inc., Cardiovascular Division, Santa
Rosa, California (the subject firm). The Department's Notice of
Affirmative Determination was published in the Federal Register on
August 27, 2007 (72 FR 49026). Workers produce cardiovascular stents
(also known as coronary stents).
The initial investigation revealed that the subject firm did not
import cardiovascular stents during the relevant period, that the
subject firm did not shift cardiovascular stent production abroad
during the relevant period, and that the subject firm sold all
cardiovascular stents to a foreign source. The Department did not
conduct a survey of customer's import purchases because the subject
firm sold all cardiovascular stents produced at the Santa Rosa facility
to a foreign facility.
In the request for reconsideration, the workers alleged that the
subject firm shifted production to Ireland.
To be certified under section (a)(2)(B) of the Trade Act, the
following must be satisfied:
A. A significant number or proportion of the workers in such
workers' firm, or an appropriate subdivision of the firm, have become
totally or partially separated, or are threatened to become totally or
partially separated;
B. There has been a shift in production by such workers' firm or
subdivision to a foreign country of articles like or directly
competitive with articles which are produced by such firm or
subdivision; and
C. One of the following must be satisfied:
1. The country to which the workers' firm has shifted production of
the articles is a party to a free trade agreement with the United
States;
2. The country to which the workers' firm has shifted production of
the articles is a beneficiary country under the Andean Trade Preference
Act, African Growth and Opportunity Act, or the Caribbean Basin
Economic Recovery Act; or
3. There has been or is likely to be an increase in imports of
articles that are like or directly competitive with articles which are
or were produced by such firm or subdivision.
During the reconsideration investigation, the Department found that
cardiovascular stent production did shift to Ireland. However, Ireland
does not have a free trade agreement with the United States and is not
named as a beneficiary country under the Andean Trade Preference Act,
the African Growth and Opportunity Act or the Caribbean Basin Economic
Recovery Act. Further, the Department found that, following the shift
of production abroad, the subject firm did not import or have plans to
import articles that are like or directly competitive with the
cardiovascular stents produced at the subject firm.
In order for the Department to issue a certification of eligibility
to apply for Alternative Trade Adjustment Assistance (ATAA), the
subject worker group must be certified eligible to apply for Trade
Adjustment Assistance (TAA). Since the subject workers are denied
eligibility to apply for TAA, the workers cannot be certified eligible
for ATAA.
Conclusion
After careful reconsideration, I affirm the original notice of
negative
[[Page 54075]]
determination of eligibility to apply for worker adjustment assistance
for workers and former workers of Medtronic, Inc., Cardiovascular
Division, Santa Rosa, California.
Signed at Washington, DC, this 11th day of September 2007.
Elliott S. Kushner,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E7-18616 Filed 9-20-07; 8:45 am]
BILLING CODE 4510-FN-P